Anastasia Khvorova

2011 - Galena Biopharma

In 2011, Anastasia Khvorova earned a total compensation of $389.3K as Chief Scientific Officer, RXi Pharmaceuticals Corporation at Galena Biopharma, a 27% decrease compared to previous year.

Compensation breakdown

Bonus$7,326
Option Awards$50,000
Salary$331,667
Other$300
Total$389,293

Khvorova received $331.7K in salary, accounting for 85% of the total pay in 2011.

Khvorova also received $7.3K in bonus, $50K in option awards and $300 in other compensation.

Rankings

In 2011, Anastasia Khvorova's compensation ranked 8,761st out of 10,747 executives tracked by ExecPay. In other words, Khvorova earned more than 18.5% of executives.

ClassificationRankingPercentile
All
8,761
out of 10,747
19th
Division
Manufacturing
3,270
out of 3,960
17th
Major group
Chemicals And Allied Products
821
out of 1,033
21st
Industry group
Drugs
604
out of 781
23rd
Industry
Pharmaceutical Preparations
462
out of 571
19th
Source: SEC filing on April 30, 2012.

Khvorova's colleagues

We found five more compensation records of executives who worked with Anastasia Khvorova at Galena Biopharma in 2011.

2011

Mark Ahn

Galena Biopharma

Chief Executive Officer

2011

Noah Beerman

Galena Biopharma

Chief Executive Officer

2011

Mark Schwartz

Galena Biopharma

Chief Operating Officer

2011

Pamela Pavco

Galena Biopharma

Vice President of Pharmaceutical Development, RXi Pharmaceuticals Corporation

2011

Kwang Lee

Galena Biopharma

Vice President of Finance

You may also like